Invention Grant
- Patent Title: Rubella virus spike construct
-
Application No.: US15734263Application Date: 2020-02-14
-
Publication No.: US11780884B2Publication Date: 2023-10-10
- Inventor: Thomas Schumacher , Hugo Arends
- Applicant: Institut Virion \ Serion GmbH , Judith Stuermer
- Applicant Address: DE Wuerzburg
- Assignee: Judith Stuermer,Institut Virion \ Serion GmbH
- Current Assignee: Judith Stuermer,Institut Virion \ Serion GmbH
- Current Assignee Address: DE Wuerzburg; DE Wuerzburg
- Agency: Collard & Roe, P.C.
- Priority: DE 2019004812.1 2019.07.10
- International Application: PCT/DE2020/000024 2020.02.14
- International Announcement: WO2021/004561A 2021.01.14
- Date entered country: 2020-12-02
- Main IPC: C12N7/00
- IPC: C12N7/00 ; C07K14/005 ; A61K39/20 ; G01N33/569

Abstract:
The Rubella Virus Spike construct comprises at least one E1 component and one E2 component, which are linked together. The E1 component consists of the El envelope protein, whose C-terminal transmembrane region and intravirional domain are removed and whose N-terminus comprises the ectodomain of the El envelope protein. The E2 component consists of the E2 envelope protein whose transmembrane regions and intravirional domain removed and whose C-terminus comprising the ectodomain of the E2 envelope protein.
The C-terminus of the E2 component is connected to the N-terminus of the E1 component by direct fusion or by means of a linker to form an E1-E2 fusion protein.
The C-terminus of the E2 component is connected to the N-terminus of the E1 component by direct fusion or by means of a linker to form an E1-E2 fusion protein.
Public/Granted literature
- US20210261624A1 RUBELLA VIRUS SPIKE CONSTRUCT Public/Granted day:2021-08-26
Information query